Catalyst Wire Dossier Catalyst Wire Dossier

Telmisartan/amlodipine 80 mg/5 mg FDC Tablet

telmisartan/amlodipine · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Telmisartan/amlodipine 80 mg/5 mg FDC Tablet, covering 2012-08-27 to 2012-08-27. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg FDC Tablet and Telmisartan 80 mg Tab and Amlodipine 5 mg Tab Concomitant Use [Phase 1]

See pricing